


Politique d’Investissement Responsable – Juin 2025

Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia

Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease

SparingVision Presents PRODYGY data and Research Update in Two Oral Presentations at ASGCT 2025
